Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14.1K | Jun 5, 2024 | Direct | ||
Orchard Therapeutics plc | Director | Ordinary Shares | 0 | $0.46 | Jan 24, 2024 | Direct | |
Orchard Therapeutics plc | Director | Stock Option (Right to Buy) | 0 | Jan 24, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATXS | Astria Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 6, 2024 | Director |
ORTX | Orchard Therapeutics plc | Jan 24, 2024 | 3 | $0 | 4 | Jan 24, 2024 | Director |
ORTX | Orchard Therapeutics plc | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
ATXS | Astria Therapeutics, Inc. | Jun 2, 2023 | 1 | $0 | 4 | Jun 6, 2023 | Director |
ATXS | Astria Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4/A | Jun 21, 2022 | Director |
ORTX | Orchard Therapeutics plc | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
ORTX | Orchard Therapeutics plc | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
ATXS | CATABASIS PHARMACEUTICALS INC | Jun 2, 2021 | 1 | $0 | 4 | Jun 2, 2021 | Director |